Document Detail


Weight change during pharmacological blockade of interleukin-6 or tumor necrosis factor-α in patients with inflammatory rheumatic disorders: A 16-week comparative study.
MedLine Citation:
PMID:  23228348     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Interleukin (IL)-6 -/- mice develop spontaneous mature onset obesity, while the influence of the pharmacological blockade of IL-6 on body weight in humans has not been previously reported. The aim of the present study was to observe weight change in patients treated with tocilizumab (TCZ). METHODS: Twenty-one consecutive patients who started new treatment with TCZ were enrolled in the study. Sixteen consecutive patients who started treatment with infliximab (IFX) formed the control group. Height and weight of all patients were registered and Body Mass Index (BMI) calculated before the first treatment and at week 16. The Mann-Whitney or paired Wilcoxon test were used for comparisons between or within groups, respectively. RESULTS: The study demonstrated that treatment with TCZ was accompanied with significant weight gain and BMI increase (p=0.04), while IFX treatment did not result in any significant weight change during the 16-week period. CONCLUSIONS: Weight gain can be seen in some patients during the pharmacological blockade of IL-6. The phenomenon and metabolic pathways involved should be further investigated.
Authors:
Said Younis; Itzhak Rosner; Doron Rimar; Nina Boulman; Michael Rozenbaum; Majed Odeh; Gleb Slobodin
Related Documents :
19998238 - Transient salt wasting in pomc-deficiency due to infection induced stress.
14720528 - Overweight and obesity in patients with established coronary heart disease: are we meet...
18418528 - Patients' perception of transnasal gastroscopy.
7233298 - Continuous monitoring of uterine contractions to control intra-amniotic administration ...
3653178 - Thyroid function in patients with breast cancer.
10463728 - Is diagnostic arthroscopy of the hip worthwhile? a prospective review of 328 adults inv...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-7
Journal Detail:
Title:  Cytokine     Volume:  -     ISSN:  1096-0023     ISO Abbreviation:  Cytokine     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9005353     Medline TA:  Cytokine     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
Affiliation:
Rheumatology, Bnai Zion Medical Center, Haifa, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The protective effects of T cell deficiency against brain injury are ischemic model-dependent in rat...
Next Document:  Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding...